Rankings
▼
Calendar
CMMB Q2 2025 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena
CMMB
Chemomab Therapeutics Ltd.
$12M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$33,687
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-0.36
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$11M
Total Liabilities
$1M
Stockholders' Equity
$10M
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$33,687
-$26,901
-25.2%
Operating Income
-$2M
-$4M
+40.0%
Net Income
-$2M
-$4M
+43.3%
← Q1 2025
All Quarters
Q3 2025 →